VCAM1 and type 2 diabetes mellitus: In the presence of hyperinsulinemia in type 2 diabetes, it activates the MAPK signaling pathway, which in turn activates the expressions VCAM1 and E-selectin and induces the production of ROS, involved in vascular damage in diabetes, including the neurodegenerative diseases (Potenza et al., 2009).